Clinical Trial Update: Pneumococcal Vaccination for Splenectomised Thalassemia Major Patients in Indonesia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial in Indonesia completed evaluating pneumococcal vaccination in splenectomised thalassemia major patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infection
• Thalassemia Major

Drugs mentioned

• Pneumococcal vaccine (pneumococcal vaccine)

Snippet

Sponsor: Fakultas Kedokteran Universitas Indonesia | Conditions: Thalassemia, Pneumococcal Infection | Phase 4 | Status: COMPLETED